ArticleContemporary clinical trials2025
Integrating a pilot study and large trial into one adaptive design.
Article in Contemporary clinical trials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAdaptive clinical trial designs are widely adopted in industry-sponsored trials but remain limited in NIH-funded public health research due to regulatory and funding challenges. This manuscript presents the Nutricity study as a proposed framework for implementing a seamless phase II/III trial design by integrating an NIH-funded pilot trial with a potential confirmatory trial into a single adaptive design to evaluate a pediatric nutrition intervention.
methodsThe Nutricity study proposes a seamless design combining a phase II pilot (NIH COBRE program funded) with a phase III trial (pending R01 grant application). This randomized trial focuses on changes in child diet quality measured by HEI scores. Simulations compared operation characteristics including sample size, study duration, and statistical power, between the seamless design and traditional two-stage approaches across various effect scenarios.
resultsSimulations demonstrated that the proposed seamless design achieved a 37 % sample size reduction and a 34 % reduction in duration, while maintaining high probability of success (99.4 %) when the effect size was as expected. Under the null scenario, the seamless design maintained an empirically estimated Type I error rate of 5.047 %. Across other scenarios with similar resource utilization, it enhanced efficiency through early stopping for futility or improved power compared to traditional approaches.
conclusionThe Nutricity study illustrates the potential of seamless phase II/III adaptive designs to improve efficiency in public health research, by integrating pilot and confirmatory phases while preserving scientific integrity. This proposed approach offers a valuable model for future NIH-funded studies adopting innovative trial methodologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.